Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Immunity

• Publication date

  2016-10-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.immuni.2016.09.009PMID 27717798
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chemokine receptor patterns in lymphocytes mirror metastatic spreading in melanoma.

  2016cited by this paper
• The influence of the microbiota on the immune response to transplantation

  2015cited by this paper
• Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

  2015influential reference
• Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy

  2015cited by this paper
• Microbially driven TLR5-dependent signaling governs distal malignant progression through tumor-promoting inflammation.

  2015cited by this paper
• Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection.

  2015cited by this paper
• Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer.

  2015cited by this paper
• Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial.

  2015cited by this paper
• Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack.

  2015cited by this paper
• T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial.

  2015cited by this paper
• Cancer and the gut microbiota: An unexpected link

  2015influential reference
• Aggressive Bakterien der Darmflora bei CED durch IgA-Coating identifiziert!

  2015cited by this paper
• The cytosolic bacterial peptidoglycan sensor Nod2 affords stem cell protection and links microbes to gut epithelial regeneration.

  2014cited by this paper
• Antibacterial, anti-inflammatory and probiotic potential of Enterococcus hirae isolated from the rumen of Bos primigenius

  2014cited by this paper
• Microbes, microbiota, and colon cancer.

  2014cited by this paper
• The gut microbiota, bacterial metabolites and colorectal cancer

  2014cited by this paper
• Enterococcal Bacteriocins and Antimicrobial Proteins that Contribute to Niche Control

  2014cited by this paper
• Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease.

  2014cited by this paper
• Intestinal Microbiota Reduces Genotoxic Endpoints Induced By High-Energy Protons

  2014cited by this paper
• Intestinal Microbiota Containing Barnesiella Species Cures Vancomycin-Resistant Enterococcus faecium Colonization

  2013cited by this paper
• The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide

  2013influential reference
• Contributions of dendritic cells and macrophages to intestinal homeostasis and immune defense

  2013cited by this paper
• Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment

  2013influential reference
• Mortality in Kittens Is Associated with a Shift in Ileum Mucosa-Associated Enterococci from Enterococcus hirae to Biofilm-Forming Enterococcus faecalis and Adherent Escherichia coli

  2013influential reference
• Fecal Microbiota Transplantation for Clostridium difficile Infection: Systematic Review and Meta-Analysis

  2013cited by this paper
• Dietary intervention impact on gut microbial gene richness

  2013cited by this paper
• Richness of human gut microbiome correlates with metabolic markers

  2013cited by this paper
• Mucosal Imprinting of Vaccine-Induced CD8+ T Cells Is Crucial to Inhibit the Growth of Mucosal Tumors

  2013cited by this paper
• A Crypt-Specific Core Microbiota Resides in the Mouse Colon

  2012cited by this paper
• Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota.

  2012cited by this paper
• Antibiotic overuse: Stop the killing of beneficial bacteria

  2011cited by this paper
• Immunomodulatory effects of cyclophosphamide and implementations for vaccine design

  2011cited by this paper
• Blockade of cytotoxic T-lymphocyte antigen-4 by ipilimumab results in dysregulation of gastrointestinal immunity in patients with advanced melanoma.

  2010cited by this paper
• Bacteria Associated with Immunoregulatory Cells in Mice

  2009cited by this paper
• Enterocolitis in Patients With Cancer After Antibody Blockade of Cytotoxic T-Lymphocyte–Associated Antigen 4

  2008cited by this paper
• Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling.

  2007cited by this paper
• Influence of antibiotic treatment on breast carcinoma development in proto-neu transgenic mice.

  2006cited by this paper
• The Shiga toxin B‐subunit targets antigen in vivo to dendritic cells and elicits anti‐tumor immunity

  2006cited by this paper
• Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4.

  2006cited by this paper
• Antibiotic use in relation to the risk of breast cancer

  2004cited by this paper
• Positional Scanning-Synthetic Peptide Library-Based Analysis of Self- and Pathogen-Derived Peptide Cross-Reactivity with Tumor-Reactive Melan-A-Specific CTL1

  2002cited by this paper

• " Pharmacomicrobiomics in blood cancers: how the gut microbiome and its metabolites shape drug efficacy and toxicity ".

  2026cites this paper
• Roles of the gut microbiota in cancer immunotherapy: mechanistic foundations and therapeutic opportunities.

  2026cites this paper
• Modulating the gut-reproductive tract axis: microbial influence on gynaecological cancer pathogenesis and treatment

  2026cites this paper
• Mucin-degrading gut bacteria: context-dependent roles in intestinal homeostasis and disease

  2026cites this paper
• Clinical Implications of Gut-Lung Axis in Systemic Chemotherapy for Lung Cancer

  2026cites this paper
• Gut microbiota and glioblastoma: composition, mechanisms, and therapeutic interventions.

  2026cites this paper
• The Gut Microbiota-Ovarian Cancer Axis: Mechanisms of Influence and Therapeutic Implications.

  2026cites this paper
• Longitudinal analysis of postoperative chemotherapy on oral-gut microbiota in patients with advanced gastric cancer

  2026cites this paper
• Correlation between gut microbiota and their metabolites and the efficacy of chemotherapy combined with immunotherapy for extensive-stage small cell lung cancer

  2026cites this paper
• Fucoidan alleviates chemotherapy-induced steatohepatitis by regulating the gut-liver axis.

  2026cites this paper
• The Role of the Microbiota in Cancer Drug Resistance and Emerging Therapeutic Strategies.

  2026cites this paper
• Exopolysaccharides from Penicillium EF-2 alleviate cyclophosphamide-induced immunosuppression and intestinal injury in mice by modulating gut microbiota and activating Nrf2/HO-1 pathway

  2026cites this paper
• Modulation of gut microbiota and short-chain fatty acids by probiotics attenuates inflammation in endometriosis

  2026cites this paper
• Microbiome modulation of tumorigenesis and immune responses

  2026cites this paper
• Microbiota translocation following intestinal barrier disruption promotes Mincle-mediated training of myeloid progenitors in the bone marrow

  2025cites this paper
• Gut Microbiota Secondary Metabolites: Key Roles in GI Tract Cancers and Infectious Diseases

  2025cites this paper
• Synergistic Interactions Between Probiotics and Anticancer Drugs: Mechanisms, Benefits, and Challenges

  2025cites this paper
• Obesity and GEP-NEN: what's new?

  2025cites this paper
• Intratumoral microbiota: understanding microbial environment of tumors

  2025cites this paper
• Microbiome-targeted nanoplatforms and engineering approaches in breast cancer therapy

  2025cites this paper
• Gut microbial metabolites in cancer immunomodulation

  2025cites this paper
• Metabolic hallmarks of type 2 diabetes compromise T cell function.

  2025cites this paper
• Modulation of Intestinal Flora: a Novel Immunotherapeutic Approach for Enhancing Thyroid Cancer Treatment

  2025cites this paper
• Role of Probiotics in Enhancing Immune Function and Improving the Effectiveness of Treatments for Pancreatic Cancer

  2025cites this paper
• The intratumor microbiome and cancer immunity: from pathogenesis to therapeutic opportunities through artificial intelligence

  2025cites this paper
• In-silico investigation reveals microbial metabolic biomarkers and their regulatory roles in hormone sensitive cancers

  2025cites this paper
• Gut microbiota interact with breast cancer therapeutics to modulate efficacy

  2025cites this paper
• Gut microbial dysbiosis, IgA, and Enterococcus in common variable immunodeficiency with immune dysregulation

  2025cites this paper
• The mechanisms and therapeutic potential of the microbiome-immune interface in cancer

  2025cites this paper
• Link between dysbiosis and cancer: Contributing mechanisms and factors.

  2025cites this paper
• Microbiome gut community structure and functionality are associated with symptom severity in non-responsive celiac disease patients undergoing a gluten-free diet

  2025cites this paper
• Influence of gut microbiota on systemic immune responses and cancer immunotherapy.

  2025cites this paper
• Highly-accurate prediction of colorectal cancer through low abundance uncultivated genomes recovered using metagenomic co-assembly and binning approach

  2025cites this paper
• The gut microbiome and cancer: from tumorigenesis to therapy

  2025cites this paper
• Nanomedicine-Driven Modulation of the Microbiota for Cancer Therapy

  2025cites this paper
• Role of gut microbiome in suppression of cancers

  2025cites this paper
• NLRs in Tumor Chemotherapy Resistance: A Double-Edged Sword.

  2025cites this paper
• New insights into gut microbiota-prostate cancer crosstalk.

  2025cites this paper
• Cancer microbiota: a focus on tumor-resident bacteria

  2025cites this paper
• Combination strategies of gut microbiota in cancer therapy through metabolic reprogramming and immune remodeling

  2025cites this paper
• Enhancement of oxaliplatin efficacy and amelioration of intestinal epithelial damage by Lactobacillus rhamnosus GG through modulation of gut microbiota

  2025cites this paper
• Role of microbiome in cancer progression.

  2025cites this paper
• Gut microbiota shapes cancer immunotherapy responses

  2025cites this paper
• Tumor-derived exosome-based microRNA-206 delivery system as dual modulators of the immune microenvironment and gut microbiota for colorectal cancer therapy.

  2025cites this paper
• The emerging role of microbiota in lung cancer: a new perspective on lung cancer development and treatment

  2025cites this paper
• A Comprehensive Oncological Biomarker Framework Guiding Precision Medicine

  2025cites this paper
• A review on the ecological niche and functional properties of enterococci in health promotion

  2025cites this paper
• Causal effects of gut microbiota on diabetic kidney disease: insights from 16S rRNA sequencing and bidirectional Mendelian randomization

  2025cites this paper
• Boosting Cancer Chemotherapy through Targeted Akkermansia muciniphila Modulation by Tumor-Repopulating Cell-Derived Microparticles.

  2025cites this paper
• Efficacy, safety, and predictive biomarkers of neoadjuvant nab-paclitaxel and pembrolizumab in hormone receptor-positive breast cancer: A randomized pilot trial

  2025cites this paper
• Dietary resistant starch protects against post-antibiotic intestinal damage by restoring microbial homeostasis and preserving intestinal barrier function in meat duck

  2025cites this paper
• Consumer Perception, Sensory Acceptance, and Microbial Characterization of Artisanal Milk Kefir During Shelf Life.

  2025cites this paper
• Harnessing the Microbiome: CRISPR-Based Gene Editing and Antimicrobial Peptides in Combating Antibiotic Resistance and Cancer

  2025cites this paper
• Research status of the relationship between microecological imbalance and lung cancer

  2025cites this paper
• GUT MICROBIOME IN CANCER: THE NEXT BIG OPPORTUNITY FOR BETTER PATIENT OUTCOMES?

  2025cites this paper
• Gut microbiome is associated with radiotherapy response in lung cancer patients with brain metastases

  2025cites this paper
• Lower respiratory tract microbiome dysbiosis impairs clinical responses to immune checkpoint blockade in advanced non‐small‐cell lung cancer

  2025cites this paper
• Engineered Bacteria for Disease Diagnosis and Treatment Using Synthetic Biology

  2025cites this paper
• Gut–X axis

  2025cites this paper
• Advancements in the Pathogenesis, Diagnosis, and Therapeutic Implications of Intestinal Bacteria

  2025cites this paper
• Tumor microbiome: roles in tumor initiation, progression, and therapy

  2025cites this paper
• Mixed supplementation of dietary inorganic and organic selenium modulated systemic health parameters and fecal microbiota in weaned pigs

  2025cites this paper
• Friends close, enemies closer: the complex role of the microbiome in antitumor immunity.

  2025cites this paper
• Interaction of environmental fluoride exposure and gut microbes: potential implication in the development of fluorosis in human subjects.

  2025cites this paper
• Unveiling roles of beneficial gut bacteria and optimal diets for health

  2025cites this paper
• Novel therapeutic strategies and recent advances in gut microbiota synergy with nanotechnology for colorectal cancer treatment

  2025cites this paper
• Decoding the Tumor-Associated Microbiota: From Origins to Nanomedicine Applications in Cancer Therapy

  2025cites this paper
• Stenotrophomonas maltophilia promotes wheat growth by enhancing nutrient assimilation and rhizosphere microbiota modulation

  2025cites this paper
• Gut Microbiota, Breast Cancer, and Neoadjuvant Therapy

  2025cites this paper
• Exploring effects of gut microbiota on tertiary lymphoid structure formation for tumor immunotherapy

  2025cites this paper
• Effect of Helicobacter Pylori infection on immunotherapy for gastrointestinal cancer: a narrative review.

  2025cites this paper
• Microbiome as a predictive biomarker in locally advanced rectal cancer

  2025cites this paper
• Impact of the ONCOBIOME network in cancer microbiome research

  2025influential citation
• Regulatory role of gut microbiota in immunotherapy of hepatocellular carcinoma

  2025cites this paper
• A Literature Review on the Impact of the Gut Microbiome on Cancer Treatment Efficacy, Disease Evolution and Toxicity: The Implications for Hematological Malignancies

  2025influential citation
• Evaluation of phytase super dosing and its combinations with other additives as an alternative to antibiotic growth promoters in broiler chickens reared in a deep litter system

  2025cites this paper
• Microbiota mechanisms in cancer progression and therapy.

  2025cites this paper
• Dysbiosis in the Gut Microbiome of Pembrolizumab‐Treated Non‐Small Lung Cancer Patients Compared to Healthy Controls Characterized Through Opportunistic Sampling

  2025cites this paper
• Gut microbiome and colorectal cancer: From pathogenesis to treatment.

  2025cites this paper
• Gut microbiome and lung cancer: mechanisms, interactions, and dietary interventions

  2025cites this paper
• Neuro-immune crosstalk in cancer: mechanisms and therapeutic implications

  2025cites this paper
• Interaction between the breast tumor microenvironment and gut microbiome

  2025cites this paper
• Research Advances in the Association between Gut Microbiota and HER2-Positive Breast Cancer

  2025cites this paper
• Unveiling the probiotic potential of Enterococcus spp.: Mechanisms and roles in animal and human health, A comprehensive review

  2025cites this paper
• Role of Human Microbiome in Development and Management of Head and Neck Squamous Cell Carcinoma

  2025cites this paper
• Common inherited loss-of-function mutations in the innate sensor NOD2 contribute to exceptional immune response to cancer immunotherapy

  2025cites this paper
• The microbiota in radiotherapy-induced cancer immunosurveillance

  2025cites this paper
• Fecal microbiota transplantation in pigs: current status and future perspective

  2025cites this paper
• Gut microbiome and gastric cancer: microbial interactions and therapeutic potential

  2025cites this paper
• Effect of Lactobacillus plantarum Extracellular Vesicles on Lipid Metabolism in Mice Fed a High‐Fat Diet

  2025cites this paper
• Multi-omics analysis of a prebiotic intervention with pectin in lipid transfer proteins (LTPs) allergic patients.

  2025cites this paper
• Deconjugating taurocholic acid with Bifidobacterium to mitigate obesity-driven cancer progression by restoring CD8+ T-cell infiltration

  2025cites this paper
• The microbiome and lung cancer: microbial effects on host immune responses and treatment outcomes

  2025cites this paper
• The Microbiota–Diet–Immunity Axis in Cancer Care: From Prevention to Treatment Modulation and Survivorship

  2025cites this paper
• The microbial landscape of tumors: a deep dive into intratumoral microbiota

  2025cites this paper
• Microbiota in drug resistance.

  2025cites this paper
• Barnesiella intestinihominis improves gut microbiota disruption and intestinal barrier integrity in mice with impaired glucose regulation

  2025cites this paper
• Maternal Gut Microbiota and Metabolomic Signatures Are Potential Indicators of Neonatal Calf Birth Weight: A Preliminary Pilot Study

  2025cites this paper
• The Gut Microbiome Role in Multiple Myeloma: Emerging Insights and Therapeutic Opportunities

  2025cites this paper
• Association between gut microbiota and glioblastoma: a Mendelian randomization study

  2024cites this paper